Rong Wang | Oncology | Best Researcher Award

Posted on by sciencefather

Dr. Rong Wang | Oncology | Best Researcher Award

Dr. Rong Wang, Nanfang Hospital, Southern Medical University, China.

Dr. Rong Wang, a distinguished figure at Nanfang Hospital, Southern Medical University, has built an impressive career that bridges clinical excellence and pioneering research. From her early academic days, she showed a strong commitment to medical science, which translated into impactful professional endeavors in both patient care and research. Her primary focus lies in clinical and translational medicine, where she has made significant contributions through innovative diagnostics, treatment strategies, and interdisciplinary collaboration. Her accolades reflect her dedication, while her influence is evident in the global reach of her work and her role as a mentor and leader in the medical community.

Profile

Orcid

 

🎓 Early Academic Pursuits

Dr. Rong Wang began her academic journey with a strong foundation in medical sciences, reflecting a deep commitment to healthcare from an early stage. Her educational path was marked by excellence, as she pursued rigorous training in clinical medicine and specialized disciplines. Her formative years at esteemed institutions prepared her with a robust understanding of both theoretical and practical dimensions of medical research, setting the stage for a remarkable professional trajectory.

🏥 Professional Endeavors

Currently affiliated with Nanfang Hospital at Southern Medical University, China, Dr. Rong Wang has established herself as a dedicated clinician and researcher. Her work seamlessly integrates patient care with academic inquiry, creating a dynamic synergy between hospital-based practice and medical innovation. Her role at this prestigious institution has enabled her to engage in cutting-edge research, medical education, and multidisciplinary collaborations that enhance both her personal growth and the advancement of the medical field.

🔬 Contributions and Research Focus

Dr. Wang’s research interests are deeply embedded in clinical and translational medicine, particularly focusing on emerging healthcare challenges in China and globally. Her investigations often revolve around innovative diagnostic techniques, treatment protocols, and patient-centered care strategies. With a vision to bridge the gap between laboratory research and bedside application, her contributions have not only enriched scientific literature but also improved therapeutic outcomes.

🏅 Accolades and Recognition

Over the years, Dr. Rong Wang has been the recipient of numerous accolades that reflect her unwavering dedication to medicine and research. Her work has garnered respect from peers and institutions alike, earning her prestigious awards and invitations to speak at national and international conferences. These honors underscore her role as a thought leader and innovator in the field.

🌏 Impact and Influence

Dr. Wang’s influence extends beyond the walls of her hospital. Her research has informed public health policies and contributed to global discourses on health equity and innovation. She actively collaborates with other researchers and healthcare professionals to promote knowledge exchange, medical training, and sustainable healthcare models. Her mentorship has inspired a new generation of researchers and medical practitioners who are carrying forward her legacy of excellence and empathy.

🌟 Legacy and Future Contributions

As she continues to evolve in her career, Dr. Rong Wang remains committed to pioneering research and medical advancement. Her future aspirations include expanding her research on integrative healthcare solutions and influencing healthcare reform through evidence-based policies. Through her persistent efforts, she aims to leave a lasting legacy marked by innovation, compassion, and societal impact.

🧠 Research-Driven Innovation

At the core of Dr. Wang’s professional identity is her relentless pursuit of scientific truth and practical solutions. Her research embodies a spirit of curiosity and a drive to solve complex medical challenges. Whether through publishing in high-impact journals or leading clinical trials, she consistently pushes the boundaries of knowledge, aiming to bring transformative change to patient care and health systems.

publication

  • Title: Establishment and Characterization of a Brain Parenchymal Metastatic Cell Line AlmoR1 Derived From an NSCLC Patient With EGFR‐TKI Resistance
    Authors: Jingyi Wu, Xiangfei Wu, Jing Wang, Guili Feng, Yuhan Wang, Zide Chen, Wei Wang, Rong Wang
    Year: 2025

 

  • Title: Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
    Authors: Rong Wang, Tadaaki Yamada, Kenji Kita, Hirokazu Taniguchi, Sachiko Arai, Koji Fukuda, Minoru Terashima, Akihiko Ishimura, Akihiro Nishiyama, Azusa Tanimoto, et al.
    Year: 2020

 

🔚 Conclusion

With a future-oriented mindset and an unwavering commitment to advancing healthcare, Dr. Rong Wang stands as a beacon of medical innovation and compassion. Her career is a testament to how scientific research and clinical practice can come together to improve lives and shape the future of medicine. As she continues her journey, her legacy will be defined by her transformative contributions, the people she has inspired, and the advancements she has helped bring to life in the world of healthcare.

Zewen Cheng | Clinical Medicine | Young Scientist Award

Posted on by sciencefather

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,  China.

Zewen Cheng’s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

 

🎓 Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

🏥 Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

🔬 Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

🏆 Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

💪 Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

🌟 Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

 

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

 

🏆 Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.

 

 

Hui-Hsin Ko | Oral oncology | Best Researcher Award

Posted on by sciencefather

Dr. Hui-Hsin Ko | Oral oncology | Best Researcher Award

Dr . Hui-Hsin Ko National Taiwan University Hsin-Chu Hospital Taiwan

Dr. Hui-Hsin Ko is an Assistant Professor and the Head of the Oral & Maxillofacial Surgery Division at National Taiwan University Hsin-Chu Hospital. With a DDS, MS, and PhD from National Taiwan University, she has extensive expertise in oral and maxillofacial surgery, specializing in cancer surgeries, temporomandibular joint (TMJ) surgeries, and zygomatic implantation. Dr. Ko’s research focuses on oral squamous cell carcinoma, with multiple publications in SCI-indexed journals. She has contributed significantly to the field of cancer research by exploring biomarkers such as AKR1B10, advancing both the understanding and treatment of oral cancers. Dr. Ko’s achievements in research and clinical practice have set a high standard for innovation in her field.

 

profile

scopus

Academic and Professional Background 🎓

Dr. Hui-Hsin Ko is a Clinical Assistant Professor at National Taiwan University and the Head of the Oral & Maxillofacial Surgery Division at National Taiwan University Hospital, Hsin-Chu Branch. She holds a DDS, MS, and PhD from National Taiwan University, with specialization in oral and maxillofacial surgery. Her expertise includes temporomandibular joint surgery, cancer surgery, and zygomatic implantation. A diplomate of the Taiwan Board of Oral and Maxillofacial Surgery, Dr. Ko has authored several publications, significantly contributing to oral squamous cell carcinoma research.

Research and Innovations 💡

Completed/Ongoing Research Projects: AKR1B10-related, TMJ arthroscopy-related, oral cancer-related.Citation Index: Information available on indexed platformsConsultancy/Industry Projects: To be updated Books Published (ISBN): No books published yet.Patents Published/Under Process: To be updated.Journals Published (SCI, Scopus, etc.): Multiple articles published in SCI-indexed journals

Editorial Appointments ✍️

To be updated.

Collaborations 🤝

Dr. Ko has actively collaborated with medical professionals and researchers in Taiwan to advance studies in oral squamous cell carcinoma and oral health-related surgeries.

Professional Memberships 📜

Diplomate of the Taiwan Board of Oral and Maxillofacial Surgery.Member of various oral and maxillofacial surgical associations

Areas of Research 🔬

Oral squamous cell carcinoma.Temporomandibular joint surgery.Zygomatic implantation.Cancer surgery

Contributions 🌟

Dr. Hui-Hsin Ko has significantly contributed to cancer research, especially in identifying biomarkers for oral squamous cell carcinoma progression. Her work on AKR1B10 levels has opened new pathways in understanding the poor prognosis of the disease. She has also explored advanced surgical techniques, including TMJ surgery and zygomatic implantation, contributing to improved patient outcomes.

 

📚 Publications

  • Title: The dental implant survival rate in 18 patients with post-operation revolutionary jaw reconstruction using free fibular flap, dental implants, and overdentures
    Author(s): Ko, H.-H., Chou, C.-H., Cheng, S.-J.
    Year: 2024

 

  • Title: Fibroblast growth factor 5 expression predicts the progression of oral squamous cell carcinoma
    Author(s): Shie, W.-Y., Cheng, S.-J., Chen, K.-C., Hou, H.-H., Elizabeth Chou, H.-Y.
    Year: 2024

 

  • Title: Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines
    Author(s): Ko, H.-H., Chou, H.-Y.E., Hou, H.-H., Yen-Ping Kuo, M., Cheng, S.-J.
    Year: 2024

 

  • Title: Prosthetic-Driven Autotransplantation with the Assistance of Medical Image-Processing Software and a Real-Time Navigation System: A Case Report
    Author(s): Chang, H.-M., Ko, H.-H., Chi, C.-W., Lin, I.-P., Chen, S.-H.
    Year: 2024

 

  • Title: Evaluation of the prognostic and therapeutic potential of inhibin beta B for oral squamous cell carcinoma
    Author(s): Chung, Y.-Y., Cheng, S.-J., Ko, H.-H., Shie, W.-Y., Elizabeth Chou, H.-Y.
    Year: 2024

 

  • Title: Metastasis and immunosuppression promoted by mtDNA and PD-L1 in extracellular vesicles are reversed by WGP β-glucan in oral squamous cell carcinoma
    Author(s): Ko, H.-H., Peng, H.-H., Cheng, A.N., Lee, A.Y.-L., Cheng, S.-J.
    Year: 2023

 

  • Title: Lysyl oxidase-like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3
    Author(s): Lu, Y.-J., Deng, Y.-T., Ko, H.-H., Kuo, M.Y.-P., Cheng, S.-J.
    Year: 2023

 

  • Title: ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions
    Author(s): Juan, Y.-C., Su, Y.-F., Bai, C.-H., Fwu, C.-W., Cheng, S.-J.
    Year: 2023

 

  • Title: β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients
    Author(s): Lo, Y.-W., Lee, A.Y.-L., Liu, Y.-C., Chiang, C.-P., Cheng, S.-J.
    Year: 2022

 

  • Title: Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan
    Author(s): Peng, H.-H., Ko, H.-H., Chi, N.-C., Kuo, M.Y.-P., Cheng, S.-J.
    Year: 2020

 

Conclusion

Dr. Hui-Hsin Ko’s extensive background in oral and maxillofacial surgery, coupled with her impressive research contributions to the understanding of oral squamous cell carcinoma, makes her a strong candidate for the Best Researcher Award. Her dedication to advancing cancer research, her innovative surgical techniques, and her collaborative efforts in the medical field demonstrate her leadership and impact. Dr. Ko has not only excelled in her clinical practice but has also significantly contributed to scientific advancements that benefit patients globally.